Literature DB >> 18066074

Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes.

Olivier Joffre1, Thibault Santolaria, Denis Calise, Talal Al Saati, Denis Hudrisier, Paola Romagnoli, Joost P M van Meerwijk.   

Abstract

A major challenge in transplantation medicine is controlling the very strong immune responses to foreign antigens that are responsible for graft rejection. Although immunosuppressive drugs efficiently inhibit acute graft rejection, a substantial proportion of patients suffer chronic rejection that ultimately leads to functional loss of the graft. Induction of immunological tolerance to transplants would avoid rejection and the need for lifelong treatment with immunosuppressive drugs. Tolerance to self-antigens is ensured naturally by several mechanisms; one major mechanism depends on the activity of regulatory T lymphocytes. Here we show that in mice treated with clinically acceptable levels of irradiation, regulatory CD4+CD25+Foxp3+ T cells stimulated in vitro with alloantigens induced long-term tolerance to bone marrow and subsequent skin and cardiac allografts. Regulatory T cells specific for directly presented donor antigens prevented only acute rejection, despite hematopoietic chimerism. By contrast, regulatory T cells specific for both directly and indirectly presented alloantigens prevented both acute and chronic rejection. Our findings demonstrate the potential of appropriately stimulated regulatory T cells for future cell-based therapeutic approaches to induce lifelong immunological tolerance to allogeneic transplants.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18066074      PMCID: PMC2443705          DOI: 10.1038/nm1688

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  30 in total

1.  Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific.

Authors:  A M Thornton; E M Shevach
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

Review 2.  Mixed chimerism and transplant tolerance.

Authors:  M Sykes
Journal:  Immunity       Date:  2001-04       Impact factor: 31.745

3.  Preventing NK cell activation by donor dendritic cells enhances allospecific CD4 T cell priming and promotes Th type 2 responses to transplantation antigens.

Authors:  Jérôme D Coudert; Christiane Coureau; Jean-Charles Guéry
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

4.  Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes.

Authors:  Olivier Joffre; Nathalie Gorsse; Paola Romagnoli; Denis Hudrisier; Joost P M van Meerwijk
Journal:  Blood       Date:  2004-02-19       Impact factor: 22.113

Review 5.  Effector mechanisms in transplant rejection.

Authors:  Paulo N Rocha; Troy J Plumb; Steven D Crowley; Thomas M Coffman
Journal:  Immunol Rev       Date:  2003-12       Impact factor: 12.988

6.  Non-myeloablative mixed chimerism approaches and tolerance, a split decision.

Authors:  Bin Luo; William F N Chan; A M James Shapiro; Colin C Anderson
Journal:  Eur J Immunol       Date:  2007-05       Impact factor: 5.532

Review 7.  Aims of conditioning.

Authors:  Huib M Vriesendorp
Journal:  Exp Hematol       Date:  2003-10       Impact factor: 3.084

Review 8.  Mixed chimerism and transplantation tolerance.

Authors:  A Benedict Cosimi; David H Sachs
Journal:  Transplantation       Date:  2004-03-27       Impact factor: 4.939

9.  Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo.

Authors:  Shuiping Jiang; Niels Camara; Giovanna Lombardi; Robert I Lechler
Journal:  Blood       Date:  2003-05-29       Impact factor: 22.113

10.  Regulatory T cells mediate maternal tolerance to the fetus.

Authors:  Varuna R Aluvihare; Marinos Kallikourdis; Alexander G Betz
Journal:  Nat Immunol       Date:  2004-02-01       Impact factor: 25.606

View more
  207 in total

1.  Correlation between post transplant maternal microchimerism and tolerance across MHC barriers in mice.

Authors:  Partha Dutta; William J Burlingham
Journal:  Chimerism       Date:  2011-07-01

Review 2.  CD4(+)Foxp3(+) regulatory T cell therapy in transplantation.

Authors:  Qizhi Tang; Jeffrey A Bluestone; Sang-Mo Kang
Journal:  J Mol Cell Biol       Date:  2011-12-14       Impact factor: 6.216

Review 3.  Learning to live together: harnessing regulatory T cells to induce organ transplant tolerance.

Authors:  Andrew Y Chang; Nupur Bhattacharya
Journal:  Yale J Biol Med       Date:  2011-12

Review 4.  Mixed chimerism and split tolerance: mechanisms and clinical correlations.

Authors:  David P Al-Adra; Colin C Anderson
Journal:  Chimerism       Date:  2011 Oct-Dec

5.  Comparative study of regulatory T cells expanded ex vivo from cord blood and adult peripheral blood.

Authors:  Huahua Fan; Jie Yang; Jun Hao; Yana Ren; Liang Chen; Guiping Li; Rufeng Xie; Yiming Yang; Feng Gao; Mingyao Liu
Journal:  Immunology       Date:  2012-06       Impact factor: 7.397

Review 6.  Transplantation tolerance through mixed chimerism.

Authors:  Nina Pilat; Thomas Wekerle
Journal:  Nat Rev Nephrol       Date:  2010-08-31       Impact factor: 28.314

Review 7.  An update on regulatory T cells in transplant tolerance and rejection.

Authors:  Xian Chang Li; Laurence A Turka
Journal:  Nat Rev Nephrol       Date:  2010-08-03       Impact factor: 28.314

8.  The role of sildenafil in the development of transplant arteriosclerosis in rat aortic grafts.

Authors:  Shuai Luo; Mei Yang; Hao Jin; Zi-Qiang Xu; Yi-Fu Li; Peng Xia; Yi-Rrong Yang; Bi-Cheng Chen; Yan Zhang
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

9.  Incomplete clonal deletion as prerequisite for tissue-specific minor antigen tolerization.

Authors:  Nina Pilat; Benedikt Mahr; Lukas Unger; Karin Hock; Christoph Schwarz; Andreas M Farkas; Ulrike Baranyi; Fritz Wrba; Thomas Wekerle
Journal:  JCI Insight       Date:  2016-05-19

10.  Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients.

Authors:  Giorgio Raimondi; Tina L Sumpter; Benjamin M Matta; Mahesh Pillai; Natasha Corbitt; Yoram Vodovotz; Zhiliang Wang; Angus W Thomson
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.